Sigma-Aldrich's Q3 Revenues, R&D Spend Rise 14 Percent as Profit Grows 5 Percent | GenomeWeb
NEW YORK (GenomeWeb News) — Sigma-Aldrich yesterday said third-quarter revenue rose 14 percent as R&D spending increased 14 percent and profit widened 5 percent.
 
Total receipts for the three months ended Sept. 30 increased to $503.2 million from $441.4 million year over year.
 
R&D spending increased to $15 million from $13.2 million year over year.
 
The company said profit increased to $71.6 million from $68.4 million in the year-ago period. 
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.